Working with stakeholders across the medical device ecosystem to catalyze the timely, reliable, and cost-effective development of Real-World Evidence to enhance regulatory and clinical decision-making.
NESTcc panel at MDIC Annual Public Forum 2017. Watch the session here.
NESTcc is pleased to announce that on February 12, 2019, the MDIC Board of Directors confirmed Jennifer Luray, […]
On January 30, 2019, NESTcc convened the first meeting of its Active Surveillance Task Force. This multi-stakeholder group […]
On December 13, 2018, the NESTcc Governing Committee approved the establishment of a small, multi-stakeholder Active Surveillance Task […]
Read NESTcc Executive Director @Fleurence and NESTcc Governing Committee Member Dr. Jeff Shuren’s update on the role of NESTcc in advancing Real-World Evidence (RWE) for #medicaldevices. twitter.com/Fleurence/stat…
FDA Commissioner @SGottliebFDA addresses the evolving landscape of #medicaldevice materials, postmarket device safety concerns, and how NESTcc will leverage #realworlddata to help FDA act on these concerns. twitter.com/SGottliebFDA/s…
NESTcc welcomes Jennifer Luray, MPA, Senior Advisor at @ResearchAmerica as the newest member of the NESTcc Governing Committee. Read more about Ms. Luray and the unique perspective she brings to NESTcc governance: bit.ly/2EcS9t0 pic.twitter.com/4o1JnUCRKl
Less than a month in, 2019 is shaping up to be another landmark year for the NESTcc. In an effort to further advance our mission to accelerate the development and […]